Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tilray Brands, Inc. TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis business, Distribution business, Beverage alcohol business and Wellness business. The Cannabis business segment is engaged in the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. The Distribution business segment is focused on the purchase and resale of pharmaceutical products to customers. The Beverage alcohol business segment is engaged in the production, marketing and sale of beverage and beverage alcohol products. The Wellness business segment includes hemp foods and hemp-based cannabidiol (CBD) consumer products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Bake Sale, XMG, Mollo, and others.


NDAQ:TLRY - Post by User

Post by DaveInCalgaryon Mar 08, 2023 5:27pm
166 Views
Post# 35326937

German Legalization Progressing

German Legalization Progressing
cannabis
Time: Wednesday, March 15, 2023, 2:45 p.m. to 3:45 p.m.
Place: Berlin, Paul-Lbe-Haus, meeting room E 300
 
Draft law by the parliamentary group DIE LINKE.
Draft Law Amending Narcotics Act - Decriminalizing Cannabis BT paper
20/2579
 
Motion by the CDU/CSU parliamentary group
to improve patient care with cannabis medicines - education and prevention for children and young people strengthen BT printed matter
20/5561
List of Experts
Verbnde/Institutionen • Branchenverband Cannabiswirtschaft e. V. (BvCW)1 • Bund Deutscher Kriminalbeamter e. V. (BDK)1 • Deutsche Hauptstelle fr Suchtfragen e. V. (DHS)1 • Deutscher Hanfverband (DHV)2 • Deutscher Richterbund e. V. (DRB)1 Einzelsachverstndige • Johannes Ertelt (Verband der Cannabis versorgenden Apotheken e. V. (VCA))3 • Prof. Dr. Justus Haucap (Universitt Dsseldorf) 1 • Dr. Robin Hofmann (Universitt Maastricht) 1 • Dr. Ursula Marschall (Barmer, Leitende Medizinerin) 3 • Dr. Michelle Murti (Ontario Ministry of Health, Associate Chief Medical Officer of Health, Public Health)1 • Kai-Friedrich Niermann (KFN + Rechtsanwaltskanzlei) 2 • Sebastian Schtze (Bundesverband der Pharmazeutischen Industrie e.V. (BPI))3 • Prof. Dr. Heino Stver (Universitt Frankfurt) 1 • Hubert Wimber (Law Enforcement Against Prohibition Deutschland)

https://www.bundestag.de/ausschuesse/a14_gesundheit/oeffentliche_anhoerungen/936104-936104
<< Previous
Bullboard Posts
Next >>